140 related articles for article (PubMed ID: 10994725)
1. Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss.
Carnevale V; Dicembrino F; Frusciante V; Chiodini I; Minisola S; Scillitani A
J Nucl Med; 2000 Sep; 41(9):1478-83. PubMed ID: 10994725
[TBL] [Abstract][Full Text] [Related]
2. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
4. Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.
Frusciante V; Carnevale V; Scillitani A; Zingrillo M; Dicembrino F; Giannatempo GM; Ghiggi MR; Minisola S
Eur J Nucl Med; 1998 Feb; 25(2):139-43. PubMed ID: 9473261
[TBL] [Abstract][Full Text] [Related]
5. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in the global skeletal uptake of technetium-99m methylene diphosphonate in healthy women.
Carnevale V; Frusciante V; Scillitani A; Modoni S; Pileri M; Chiodini I; Dicembrino F; Romagnoli E; Minisola S
Eur J Nucl Med; 1996 Nov; 23(11):1473-7. PubMed ID: 8854845
[TBL] [Abstract][Full Text] [Related]
7. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
8. Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis.
Moore AE; Blake GM; Taylor KA; Ruff VA; Rana AE; Wan X; Fogelman I
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):326-36. PubMed ID: 22057627
[TBL] [Abstract][Full Text] [Related]
9. Age-related normal uptake of 99mTc-MDP in the lower spine.
Sundkvist GM; Lilja B; Mattsson S
Nuklearmedizin; 1997 Mar; 36(2):52-5. PubMed ID: 9090647
[TBL] [Abstract][Full Text] [Related]
10. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
[TBL] [Abstract][Full Text] [Related]
12. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
13. Relationship between skeletal uptake of 99mTc-HMDP and bone mineral density in elderly women.
Kigami Y; Yamamoto I; Ohnishi H; Takada M; Matsushita R; Hamanaka Y; Ota T; Morita R
Ann Nucl Med; 1998 Feb; 12(1):15-20. PubMed ID: 9559957
[TBL] [Abstract][Full Text] [Related]
14. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis.
Israel O; Lubushitzky R; Frenkel A; Iosilevsky G; Bettman L; Gips S; Hardoff R; Baron E; Barzilai D; Kolodny GM
J Nucl Med; 1994 Jul; 35(7):1155-8. PubMed ID: 8014674
[TBL] [Abstract][Full Text] [Related]
16. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
D'Addabbo A; Rubini G; Mele M; Lauriero F
Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
Kaye J; Hayward M
Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
[TBL] [Abstract][Full Text] [Related]
18. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.
Brenner W; Sieweke N; Bohuslavizki KH; Kampen WU; Zuhayra M; Clausen M; Henze E
Nuklearmedizin; 2000 Aug; 39(5):127-32. PubMed ID: 10984888
[TBL] [Abstract][Full Text] [Related]
19. 99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.
Rubini G; Lauriero F; Rubini D; D'Addabbo A
Nucl Med Commun; 1993 Jul; 14(7):567-72. PubMed ID: 8355916
[TBL] [Abstract][Full Text] [Related]
20. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
Moore AE; Blake GM; Fogelman I
Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
